For adults with mild-to-moderate COVID-19, early administration of simnotrelvir plus ritonavir shortens the time to sustained resolution of symptoms, according to a study published in the Jan. 18 issue of the New England ...
Jan 18, 2024
0
0
A large randomized control trial conducted by a team of Neuroscience Research Australia (NeuRA) and UNSW researchers found that at-home 'gamified' step exercises were effective at preventing falls in people over the age of ...
Jan 17, 2024
1
87
Acoramidis yields a significantly better four-step primary hierarchical outcome, including aspects of mortality and morbidity, than placebo for patients with transthyretin amyloid cardiomyopathy, according to a study published ...
Jan 14, 2024
0
6
For heavily transfused patients with lower-risk myelodysplastic syndromes (LR-MDS) who are not responding to or are ineligible for erythropoiesis-stimulating agents (ESAs), the competitive telomerase inhibitor imetelstat ...
Jan 9, 2024
0
0
For children with achondroplasia, vosoritide is associated with a gain in the change in height Z score from baseline and a mild adverse event profile, according to a study published in the January issue of The Lancet Child ...
Dec 30, 2023
0
0
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according ...
Dec 22, 2023
0
0
A new treatment appears to reduce food allergies in children and teens, according to interim clinical trial results.
Dec 21, 2023
0
2
Prof. Mark Coburn and PD Dr. Ana Kowark from the Department of Anesthesiology and Operative Intensive Care Medicine at the University Hospital Bonn (UKB) have conducted the largest randomized study to date on the effect of ...
Dec 20, 2023
0
0
The biggest health and nutrition story of 2023 was arguably the exploding popularity of prescription medications to treat obesity, a chronic disease that affects more than four in 10 U.S. adults.
Dec 14, 2023
0
0
A single dose of mRNA-1345 vaccine is safe and results in lower incidence of respiratory syncytial virus (RSV)-associated disease in older patients, according to a study published in the Dec. 14 issue of the New England Journal ...
Dec 14, 2023
0
2
